Equity Overview
Price & Market Data
Price: $5.78
Daily Change: $0.00 / 0.00%
Daily Range: $0 - $0
Market Cap: $1,182,920,448
Daily Volume: 0
Performance Metrics
1 Week: 14.46%
1 Month: 9.68%
3 Months: -0.34%
6 Months: 65.62%
1 Year: 110.2%
YTD: -4.15%
Company Details
Employees: 70
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases in the United States. The company's lead product candidate is molgramostim, an inhaled granulocyte-macrophage colony-stimulating factor, which is in Phase 3 development stage for the treatment of autoimmune pulmonary alveolar proteinosis. Savara Inc. was founded in 2007 and is headquartered in Langhorne, Pennsylvania.